CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
about
A perspective on the role of estrogen in hormone-induced prostate carcinogenesisAssociation of variants in estrogen-related pathway genes with prostate cancer risk.Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapyAssociation between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.Genotypic and allelic variability in CYP19A1 among populations of African and European ancestryAromatase activity and bone loss in men.Variation in the CYP19A1 gene and risk of colon and rectal cancer.Hormones and prostate carcinogenesis: Androgens and estrogens.CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerEthnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcomeAssociation of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.Molecular basis for prostate cancer racial disparities.The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.Precision Medicine and Men's Health.Genetic Determinants of Circulating Estrogen Levels, and Evidence of a Causal Effect of Estradiol on Bone Density in Men.
P2860
Q27004552-B97B4C5A-5B17-4BBD-B9DD-DCD9276D3AA8Q30532192-52051281-455A-4410-A4E9-A9FF5A207001Q34622545-C36D12D9-F05E-407A-B3AE-EEE19F59C11FQ34763711-AAB0CA6F-5B1D-4D0B-AA67-F5CC34A586B2Q35043868-DFE9680C-A45C-4DAC-8309-E4C4BD08C76EQ35101538-ED206E5B-3C65-4FEF-8B50-CCE6B8736C6AQ35576313-98819D77-7D44-4A53-8DE4-E0CEF5732012Q35687198-4820350B-36EB-4B73-8A3C-591E3993DCA5Q36419325-A3C79DC0-BAE3-4DED-A393-AA987EB1D291Q36758880-54F178FB-3C42-44EE-B7BD-19F83EBFD0E5Q37244198-7B1E4B2A-F465-48D3-A274-7B699C1E2CE0Q39368655-7664BC03-956E-4073-A083-35E30FB50ADAQ41334556-CDDED863-DBD6-4749-AB65-CF81438E46F1Q42035769-2A892CA7-5181-4905-95CC-C43663B33689Q47151829-80FF26C0-897E-4788-92B0-233BE9DB2543Q50084303-40E5740F-F9E8-41C0-B83D-F3E94D3660B6
P2860
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@ast
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@en
type
label
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@ast
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@en
prefLabel
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@ast
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@en
P2093
P2860
P50
P1476
CYP19A1 genetic variation in r ...... tate Cancer Cohort Consortium.
@en
P2093
Daniel O Stram
Eugenia E Calle
Goran Berglund
J Michael Gaziano
Joel N Hirschhorn
Laudina Rodriguez
Laurence N Kolonel
Michael J Thun
Naomi E Allen
P2860
P304
P356
10.1158/1055-9965.EPI-09-0496
P50
P577
2009-09-29T00:00:00Z